Clinical Trial Update: Randomized Clinical Trial of Sofosbuvir in Combination With Daclatasvir or Simeprevir for 12 Weeks in Non-cirrhotic Subjects Infected With Chronic Hepatitis C Virus Genotype 1 (TNT) [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial evaluated 12-week regimens of sofosbuvir plus daclatasvir or sofosbuvir plus simeprevir in non-cirrhotic adults with chronic hepatiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Daclatasvir (daclatasvir)
• Simeprevir (simeprevir)
• Sofosbuvir (sofosbuvir)

Snippet

Sponsor: Federal University of São Paulo | Conditions: Hepatitis C, Chronic | Phase 4 | Status: COMPLETED